First resolution for 2025: I am leaving this platform for good.
Find me @bluesky
MarcAndre64.bsky.social 🦋
André Marc retweeted
#ASH24 session acknowledging the legacy of Prof. Éliane Gluckman awarded the Wallace H. Coulter award for a lifetime of achievement in cord blood transplantation.
Room packed with attendees and excitement in anticipation of the Plenary Session!
#womeninmedicine
André Marc retweeted
Big success for ELI's 10th Workshop on "Lymphoma of immune privilege sites" held last week in Stresa!
André Marc retweeted
Teaching at #ESMOAcademy, @myESMO in Zurich about #Hodgkin. Great audience.
My take home:
📣 PET CT at dx and after 2 chemo decide treatment
📣 Limit relapse check-up to 2 years, next focus on late effects
📣 Fertility counseling
📣 BrECADD new standard
📣 Nivo-AVD in elderly?
André Marc retweeted
O can safely be used in combination with chemotherapy and in maintenance after ASCT as frontline therapy in patients with MCL. ow.ly/PBYz50SFxFu #clinicatrialsandobservations #lymphoidneoplasia
André Marc retweeted
👀
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
ow.ly/2i1Z50SFwC6 #clinicaltrialsandobservations #immunobiologyandimmunotherapy #lymphoidneoplasia
André Marc retweeted
Ce 12 juillet, les pilotes de la @PAFofficiel ont laissé leurs alphajets pour venir visiter @HopSaintLouis par le biais de l’association @AssoELLyE.
Un elan du cœur pour les patients atteints de lymphome et ceux qui les soignent 🇫🇷❤️
Cc @APHP @c_thieblemont @FenauxP
André Marc retweeted
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma | Journal of Clinical Oncology ascopubs.org/doi/full/10.120…
André Marc retweeted
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma ashpublications.org/blood/ar…
André Marc retweeted
📢 Proud to see this important, timely comment by @DrLauraEsserman & @DougYeeMD just published in @NatureMedicine. I 💯 agree: Science & medical groups should stop holding conferences in anti-choice states. Abortion IS healthcare! #WomensRights
Please RT!
nature.com/articles/s41591-0…
André Marc retweeted
DESCAR-T strikes again…
Largest study on transfusion use post CART led by @HouotRoch out today in @BloodAdvances ⤵️
ashpublications.org/bloodadv…
Enjoyed writing the associated commentary with @moh7madhomod! Check it out ⤵️
ashpublications.org/bloodadv…
@MSKCancerCenter
André Marc retweeted
Final Analysis of the Ro-CHOP Trial in T-cell lymphoma: In an exploratory analysis, the median PFS in the centrally reviewed follicular helper T-cell lymphoma subgroup was significantly longer in the Ro-CHOP arm. @JCO_ASCO ascopubs.org/doi/full/10.120…
André Marc retweeted
Why some clinical trials cost >$100k per patient in one picture. #mmsm #MedTwitter
André Marc retweeted
Célébrez Noël 🎅🏼 en offrant les meilleurs équipements d’activité physique adaptée pour les patients atteints de lymphome!
Car oui, la forme physique optimise les résultats thérapeutiques.💪
Un grand merci pour votre générosité. 🎄🎁
Cc @c_thieblemont @Roberta04704608 @APHP
🌟 En cette veille des fêtes, offrez un cadeau qui compte vraiment. ✨
Le Dr @ComeBommier explique comment aider l’@HopSaintLouis @APHP à créer une salle de sport pour les patients luttant contre le cancer et l'incroyable impact de ce projet 🏋️🎁
➡️ don-hopitaux-nord.aphp.fr/sl…
André Marc retweeted
Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study ascopubs.org/doi/10.1200/JCO…
André Marc retweeted
It was such an exciting time presenting our data on SYMPATICO trial. It is a milestone achievement for our patients with mantle cell lymphoma in the world!
André Marc retweeted
Finally, analyzing 310 blood samples from 109 patients we found that #PhasEDSeq #MRD better captures relapse risk than functional imaging by PETCT. 12/15
André Marc retweeted
Thrilled to share our new study describing distinct subtypes of #HodgkinLymphoma #cHL out today @Nature. #lymsm 1/15
nature.com/articles/s41586-0… PDF link at bottom of this thread



































